Búsqueda | Portal de Búsqueda de la BVS

1.

Following aggressive B-cell lymphoma.

Sweetenham, John W.

Blood ; 125(24): 3673-4, 2015 Jun 11.

Artículo en Inglés | MEDLINE | ID: mdl-26069330

2.

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma.

Ramsey, Scott D; Nademanee, Auayporn; Masszi, Tamas; Holowiecki, Jerzy; Abidi, Muneer; Chen, Andy; Stiff, Patrick; Viviani, Simonetta; Sweetenham, John W; Radford, John; Zhu, Yanyan; Bonthapally, Vijayveer; Thomas, Elizabeth; Richhariya, Akshara; Hunder, Naomi N; Walewski, Jan; Moskowitz, Craig H.

Br J Haematol ; 175(5): 860-867, 2016 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-27649689

3.

Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies.

Roberts, Andrew W; Advani, Ranjana H; Kahl, Brad S; Persky, Daniel; Sweetenham, John W; Carney, Dennis A; Yang, Jianning; Busman, Todd B; Enschede, Sari H; Humerickhouse, Roderick A; Seymour, John F.

Br J Haematol ; 170(5): 669-78, 2015 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-25942994

4.

Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes.

Aronow, Mary E; Portell, Craig A; Sweetenham, John W; Singh, Arun D.

Ophthalmology ; 121(1): 334-341, 2014 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-24144449

5.

Mature results of MM-011: a phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma.

Lazaryan, Aleksandr; Hussein, Mohamad A; Reu, Frederic J; Faiman, Beth; Habecker, Becky; Ann Karam, Mary; Reed, Janice; Hamilton, Kimberly; Waksman, Joel; Bruening, Kellie; Srkalovic, Gordan; Andresen, Steven; Kalaycio, Matthew; Sweetenham, John W; Sobecks, Ronald; Dean, Robert; Knight, Robert; Zeldis, Jerome B; Baz, Rachid.

Am J Hematol ; 89(4): 349-54, 2014 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-24273135

6.

Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.

Aronow, Mary E; Portell, Craig A; Rybicki, Lisa A; Sweetenham, John W; Singh, Arun D.

Ophthalmology ; 120(9): 1915-9, 2013 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-23664470

7.

Characteristics of self-triaged emergency department visits by adults with cancer.

Hong, Arthur S; Hughes, Amy; Courtney, D Mark; Fullington, Hannah; Craddock Lee, Simon J; Sweetenham, John W; Sadeghi, Navid; Zhang, Song; Bazzell, Angela; Halm, Ethan A.

Am J Manag Care ; 29(9): e267-e273, 2023 09 01.

Artículo en Inglés | MEDLINE | ID: mdl-37729532

8.

Molecular signatures in the diagnosis and management of diffuse large B-cell lymphoma.

Sweetenham, John W.

Curr Opin Hematol ; 18(4): 288-92, 2011 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-21519244

9.

Proposed Algorithm for Managing Ibrutinib-Related Atrial Fibrillation.

Vrontikis, Alaina; Carey, Jessica; Gilreath, Jeffrey A; Halwani, Ahmad; Stephens, Deborah M; Sweetenham, John W.

Oncology (Williston Park) ; 30(11): 970-4, 980-1, C3, 2016 11 15.

Artículo en Inglés | MEDLINE | ID: mdl-27848243

10.

COVID-19 Communication From Seven Health Care Institutions in North Texas for English- and Spanish-Speaking Cancer Patients: Mixed Method Website Study.

Higashi, Robin T; Sweetenham, John W; Israel, Aimee D; Tiro, Jasmin A.

JMIR Cancer ; 7(3): e30492, 2021 Aug 31.

Artículo en Inglés | MEDLINE | ID: mdl-34346886

11.

Patterns and Results of Triage Advice Before Emergency Department Visits Made by Patients With Cancer.

Hong, Arthur S; Chang, Hannah; Courtney, D Mark; Fullington, Hannah; Lee, Simon J Craddock; Sweetenham, John W; Halm, Ethan A.

JCO Oncol Pract ; 17(4): e564-e574, 2021 04.

Artículo en Inglés | MEDLINE | ID: mdl-33417485

12.

Prior Frequent Emergency Department Use as a Predictor of Emergency Department Visits After a New Cancer Diagnosis.

Hong, Arthur S; Nguyen, Danh Q; Lee, Simon Craddock; Courtney, D Mark; Sweetenham, John W; Sadeghi, Navid; Cox, John V; Fullington, Hannah; Halm, Ethan A.

JCO Oncol Pract ; 17(11): e1738-e1752, 2021 11.

Artículo en Inglés | MEDLINE | ID: mdl-34038164

13.

Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide.

Dean, Robert M; Pohlman, Brad; Sweetenham, John W; Sobecks, Ronald M; Kalaycio, Matt E; Smith, Stephen D; Copelan, Edward A; Andresen, Steven; Rybicki, Lisa A; Curtis, Julie; Bolwell, Brian J.

Br J Haematol ; 148(2): 226-34, 2010 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-19821828

14.

Surviving surveillance.

Sweetenham, John W.

Oncology (Williston Park) ; 29(4): 228, 2015 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-25952484

15.

Treatment of lymphoblastic lymphoma in adults.

Sweetenham, John W.

Oncology (Williston Park) ; 23(12): 1015-20, 2009 Nov 15.

Artículo en Inglés | MEDLINE | ID: mdl-20017283

16.

Highly aggressive lymphomas in adults.

Sweetenham, John W.

Hematol Oncol Clin North Am ; 22(5): 965-78, ix, 2008 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-18954746

17.

Hodgkin lymphoma in older patients: an uncommon disease in need of study.

Evens, Andrew M; Sweetenham, John W; Horning, Sandra J.

Oncology (Williston Park) ; 22(12): 1369-79, 2008 Nov 15.

Artículo en Inglés | MEDLINE | ID: mdl-19086599

18.

A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma.

Hill, Brian T; Smith, Mitchell R; Shelley, Meredeth; Jagadeesh, Deepa; Dean, Robert M; Pohlman, Brad; Sweetenham, John W; Bolwell, Brian J; Smith, Stephen D.

Leuk Lymphoma ; 59(3): 690-694, 2018 03.

Artículo en Inglés | MEDLINE | ID: mdl-28696812

19.

"Pet negativity"--the new goal of cytoreductive therapy in Hodgkin's lymphoma?

Sweetenham, John W.

Biol Blood Marrow Transplant ; 17(11): 1569-70, 2011 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-21840291

20.

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

Press, Oliver W; Li, Hongli; Schöder, Heiko; Straus, David J; Moskowitz, Craig H; LeBlanc, Michael; Rimsza, Lisa M; Bartlett, Nancy L; Evens, Andrew M; Mittra, Erik S; LaCasce, Ann S; Sweetenham, John W; Barr, Paul M; Fanale, Michelle A; Knopp, Michael V; Noy, Ariela; Hsi, Eric D; Cook, James R; Lechowicz, Mary Jo; Gascoyne, Randy D; Leonard, John P; Kahl, Brad S; Cheson, Bruce D; Fisher, Richard I; Friedberg, Jonathan W.

J Clin Oncol ; 34(17): 2020-7, 2016 06 10.

Artículo en Inglés | MEDLINE | ID: mdl-27069074

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Following aggressive B-cell lymphoma.

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma.

Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies.

Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes.

Mature results of MM-011: a phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma.

Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.

Characteristics of self-triaged emergency department visits by adults with cancer.

Molecular signatures in the diagnosis and management of diffuse large B-cell lymphoma.

Proposed Algorithm for Managing Ibrutinib-Related Atrial Fibrillation.

COVID-19 Communication From Seven Health Care Institutions in North Texas for English- and Spanish-Speaking Cancer Patients: Mixed Method Website Study.

Patterns and Results of Triage Advice Before Emergency Department Visits Made by Patients With Cancer.

Prior Frequent Emergency Department Use as a Predictor of Emergency Department Visits After a New Cancer Diagnosis.

Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide.

Surviving surveillance.

Treatment of lymphoblastic lymphoma in adults.

Highly aggressive lymphomas in adults.

Hodgkin lymphoma in older patients: an uncommon disease in need of study.

A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma.

"Pet negativity"--the new goal of cytoreductive therapy in Hodgkin's lymphoma?

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.